Health Care Economics and Organizations: News and Research on Emergency Use Authorization

MeSH tree: N03.706.615.473.125

Mpox vaccine maker seeks approval for use in teens

Danish drugmaker Bavarian Nordic said Friday it was seeking European approval to use its mpox vaccine in children aged 12 to 17, after the WHO declared the current virus surge a global public health emergency.

Paxlovid soon will not be free for Americans

The antiviral Paxlovid has kept patients from becoming severely ill and dying from COVID-19 since it became available—at no cost to them. But by the middle of next year, the U.S. government will stop subsidizing the medication. ...